Replicate harnesses the body’s natural protein-making power and uses synthetic biology to design unique self-replicating RNAs (srRNAs) that can direct that power to fight disease. With our customizable srRNA platform and our diverse repertoire of virally derived vectors, we are tackling drug resistance in cancers and discovering new treatments for autoimmune and inflammatory disorders and other diseases. Replicate is working to make srRNA therapeutics broadly accessible, to realize their promise for all patients.



Join TechBio Companies Driving Patient Impact